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Cognitive impairmentAbstract The purpose of this study was to determine diffusion coefficient (ADC) in plaque, peri-
plaque and normal-appearing white matter (NAWM) in multiple sclerosis (MS), compare them
with the control and correlate findings with cognitive state.
Subjects and methods: Sixty-five participants were included and categorized into MS patients with
normal cognition (n= 25); MS with mild cognitive impairment (n= 20) and control group (no MS
and normal cognition; n= 20). The Montreal Cognitive Assessment was used to determine cogni-
tive state. Mean ADC was measured in plaque, peri-plaques and NAWM, compared with ADC
from corresponding white matter in control and correlated with cognitive scores. Chi Square and
Pearson correlation coefficient were used.
Results: The mean ADC of peri-plaque and NAWM in MS group with cognitive impairment was
significantly higher than MS group with normal cognition (p< 0.001) and control group (p< 0.05)
respectively. In MS patients with impaired cognition, the mean ADC in peri-plaque and NAWM
demonstrated inverse correlations with cognitive state (r= 0.64, p< 0.001) and (r= 0.56,
p= 0.01) respectively.oo.com
1010 R.M. Almolla et al.Conclusions: ADC values in peri-plaque and NAWM have an inverse correlation with cognition in
MS. The ADC is useful for detecting subtle abnormalities in white matter and can be used as a pre-
dictor of cognitive state.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
The characteristic abnormalities of multiple sclerosis (MS) in
the brain consist of multiple white matter lesions (plaques)
with high signal intensity (SI) on fluid attenuation inversion
recovery (FLAIR), Proton density (PD) WI, and T2-WI and
low SI on T1-WI. Lesions are found predominantly in a
periventricular distribution, centrum semioval, and the
calloso-septal interface. Additional sites of involvement
include other parts of the cerebral white matter such as the
subcortical white matter, optic nerves, corpus callosum, inter-
nal capsule, cerebellar peduncles, brainstem, and spinal cord
(1).
Demyelinating lesions appear smaller on T1-WI than on
T2-WI. Occasionally, they show a hyperintense border on
T1-WI. Lesions in MS can be small, large, or confluent. The
typical configuration is that of an ovoid lesion extending per-
pendicularly from the ventricular surface (Dawson’s finger).
This probably reflects the perivascular inflammation along a
penetrating medullary vein. Atypical lesions and mass-like
lesions occur with sufficient frequency to cause diagnostic
errors (1).
Recent years have witnessed increasing interest in the pre-
diction of neuropsychological (NP) impairment in patients
with MS. Approximately 50% of MS patients exhibit some
degree of NP impairment. Deficits in processing speed, mem-
ory, and higher executive function are particularly common,
affecting the quality of life and employment (2).
A cognitive impairment substantially impacts the lives of
patients with MS and their families. More than 50% of people
with MS are unemployed within ten years of diagnosis (3).
Identifying patients at risk for NP disabilities on the basis
of MRI would enhance the quality of care. It is also increas-
ingly recognized that early microstructure changes in the
normal-appearing brain tissue (NABT) may also predict cogni-
tive impairment in MS (4).
Diffusion-based imaging techniques, particularly diffusion-
weighted imaging (DWI) and diffusion-tensor imaging (DTI),
provide measures of increased pathologic specificity over con-
ventional MRI. They are able to assess in vivo the presence of
tissue damage occurring outside visible lesions, in the so-called
normal-appearing tissue (5).
Diffusion techniques measure the random movement of
water molecules in all tissues and fluid. Enhancement of such
movement in brain parenchyma probably reflects the destruc-
tion of cell membranes, and in the case of MS, demyelination,
and microscopic cell damage. Numerous studies have found
increased translational movement of water in both active
lesions and NABT in MS samples. As a result, diffusion-
related measures may account for clinical signs independent
of variance explained by more conventional, macroscopic
MRI measures (6).The purpose of this study was to utilize DWI and ADC val-
ues as a marker for early detection of MS patients susceptible
to cognitive impairment and determine the most correlated
sites (plaque, peri-plaque or normal-appearing white matter
(NAWM)) for early prediction of cognitive impairment and
to explore the correlation between water diffusion and cogni-
tion state.
2. Subjects and methods
This prospective study was carried out during the period from
December 2014 to July 2015 in Radiology and Psychiatry
department, Zagazig University, and included 45 MS patients
and 20 matched age healthy volunteers as a control. Approval
for the study from ethics committee board of our institute was
taken, as well as, a written consent from all participants after
explanation of the procedure.
2.1. Subjects
Forty-five patients (15 males and 30 females; mean age 34.22
± 7.09 year) with a clinical and radiologic diagnosis of MS
according to the McDonald criteria (7) were included in the
study. The duration of clinically evident disease was 2–11 y
(mean 4.89 ± 2.6) at the time of imaging and the number of
attacks ranged from 2 to 7.
Inclusion criteria: Relapsing remittent MS patients with no
relapse for at least 3 months before the study.
Exclusion criteria: (1) MS patient in active stage; (2) Other
intracranial pathology; (3) psychotic patients; (4) Other
major medical conditions or substance abuse; (5) Patients
on antidepressants psychoactive steroids, or immunosup-
pressive drugs; (6) Patients with delirium; (7) The presence
of any contraindications to MRI examination.
The control group 20 healthy volunteers (6 males, 14
females, mean age 35.4 ± 6.12 years) with no neurologic dis-
ability or intracranial pathology proved by clinical and con-
ventional MR examination were included.
All the patients (n= 45) and the controls group (n= 20)
underwent cognitive state assessment and MR examination
including conventional MR imaging, DW-MR imaging, and
its corresponding ADC map.
2.2. Cognitive state assessment
The Montreal Cognitive Assessment (MOCA) (8) was
designed as a rapid screening reference for mild cognitive
impairment. It is sensitively widespread and more easily used.
MOCA assesses different cognitive domains: visuospatial/exec-
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abstraction, memory (delayed recall) and orientation.
2.2.1. Criteria for mild cognitive impairment
Time to administer the MOCA was approximately 10 min. The
total possible score was 30 points; a score of 26 or above was
considered normal. We added one point for an individual, who
has 12 years or fewer of formal education. The cognitive state
was assessed by MOCA scale for all MS patients and control
group.
2.3. MRI examination
All MRI studies were done using 1.5 T MR Scanner (Achieva,
Philips Medical System). Both patients and control groups
were asked to get rid of any metallic subjects and they were
informed about the duration of the examination, the position
of the patient and the importance of being motionless. We
used a head coil had an inner diameter of 27 cm.
– Conventional magnetic resonance imaging (MRI): The con-
ventional MR sequences were done as the following: (1)
Sagittal T1WI as localizer (TE 8/TR 500). (2) Axial T1WI
(TR148-597/TE2-15). (3) Axial and Sagittal T2WI
(TR4400-4800/TE110). (4) Axial FLAIR (TR6000/TE120-
TI2000). (5) Coronal FLAIR (TR6000/TE120-TI2000).Fig. 1 32 years old female healthy control subject with MOCA s
white matter signal intensity. Quantitative ADC values of NA
0.6998  103 mm2/s.
Table 1 Demographic distribution between 3 groups.
MS group with normal cognition (25) MS g
Age: Mean ± SD 34.8 ± 7.4 33.5 ±
Sex: Male:female 17:8 13:7
NS: non-significant.Section thickness = 5 mm, gap 1 mm. Field of view
(FOV) = 240 mm in axial images and 30 mm in coronal
images Matrix 320  224.
– Diffusion-weighted MR imaging (DWI): The imaging
sequence for DWI was a multi-section single shot spin echo
EPI sequence (TR/TE/NEX: 4200/140 ms/I). The diffusion
gradients were applied sequentially in three orthogonal
directions (thickness 5 mm, FOV 240 mm, a gap of 1 mm,
and a matrix of 128  256). The total acquisition time
was 80 s. We selected b values of 0 and 1000 s/mm2 for
the calculation of ADCs. The reconstructed magnitude
images were transferred to the workstation for the calcula-
tion of the ADC values. The results of ADC values were
described as mean ± SD in units of 1  103 mm2/s.
2.4. Image analysis
All plaques were chronic and display isointense or hypointense
signal on T1-weighed images and hyperintense on T2-weighed
and FLAIR images without contrast enhancement. The
NAWM was defined as area of white matter displayed normal
signal in all pulse sequences of the conventional MR imaging.
ROI fromT2-weighted and FLAIR images was copied and
pasted onto ADC mapping images by the software system pro-
vided with the MR equipment.core 28. (A) FLAIR, (B) DWI, and (C) ADC showed normal
WM were 0.7284  103, 0.7055  103, 0.7031  103, and
roup with cognitive impairment (20) Control (20) p
6.7 35.4 ± 6.12 0.63 NS
14:6 0.94 NS
Table 2 Comparison between MS patients with cognitive impairment and MS patients without cognitive impairment as regards
MOCA scores in our study.
Cognitive function MS without CI 20 MS with CI 25 Control group 20 F p LSD
Mean ± SD Mean ± SD
1 – Visuospatial/Executive
A – Trail making test (Executive functions 0.95 ± 0.2 0.72 ± 0.1 0.95 ± 0.2 14.34 <0.001** <0.001*,a
1b
<0.001*,c
B – Visuo-constructional skill (cube) 0.90 ± 0.4 0.56 ± 0.4 0.90 ± 0.4 5.56 0.006** 0.007*,a
1b
0.007*,c
C – Visuo-constructional skill (clock) 2.85 ± 0.6 2.16 ± 0.7 2.90 ± 0.61 7.49 0.001** 0.001*,a
0.79b
<0.001*,c
Total 4.7 ± 1.2 3.44 ± 1.1 4.75 ± 1.2 9.41 <0.001** <0.001*,a
0.90b
<0.001*,c
Range 0–5 0–5 0–5
2 – Naming (X ± SD) 2.70 ± 0.6 2.12 ± 0.4 2.90 ± 0.62 12.95 <0.001** <0.001*,a
0.31b
<0.001*
Range 0–3 0–3 0–3
3 – Attention
A – Forward digit span (sustained attention) 0.95 ± 0.37 0.68 ± 0.28 0.95 ± 0.37 4.91 0.01** 0.008*,a
1b
0.008*,c
Range 0–1 0–1 0–1
B – Backward digit span (sustained attention) 0.95 ± 0.2 0.80 ± 0.27 0.95 ± 0.22 3.13 0.05* 0.04*,a
1b
0.05*,c
Range 0–1 0–1 0–1
C – Vigilance (concentration) 0.95 ± 0.16 0.80 ± 0.14 0.95 ± 0.2 6.25 0.003** 0.002*,a
1b
0.005*,c
Range 0–1 0–1 0–1
D – Serial 7 s (working memory) 2.85 ± 0.45 2.32 ± 0.42 2.90 ± 0.5 11.51 <0.001** <0.001*,a
0.74b
<0.001*,c
Range 0–3 0–3 0–3
Total 5.70 ± 0.84 4.6 ± 0.76 5.75 ± 0.86 14.63 <0.001** <0.001*,a
0.85b
<0.001*,c
Range 0–6 0–6 0–6
4 – Language (repeat and fluency) (X ± SD) 2.20 ± 0.5 1.32 ± 0.4 2.30 ± 0.5 31.15 <0.001** <0.001*,a
0.53b
<0.001*,c
Range 0–3 0–3 0–3
5 – Abstraction (X ± SD) 1.80 ± 0.5 1.2 ± 0.4 1.85 ± 0.5 14.02 <0.001** <0.001*,a
0.75b
<0.001*,c
Range 0–2 0–2 0–2
6 – Delayed recall (X ± SD) 3.95 ± 1.16 3.16 ± 1.1 4.05 ± 1.17 4.21 0.02* 0.02*,a
0.81b
0.01*,c
Range 0–5 0–5 0–5
7 – Orientation (X ± SD)
Range
6 ± 0 6 ± 0 6 ± 0 – – –
8 – Total score (X ± SD) 27.05 ± 2.3 21.84 ± 2.2 27.70 ± 2.3 46.48 <0.001** <0.001*,a
0.38b
<0.001*,c
*p 6 0.05 (significant); **p 6 0.01 (highly significant).
a MS without cognitive versus MS with cognitive.
b MS without cognitive versus control.
c MS with cognitive versus control.
1012 R.M. Almolla et al.The signal intensity values were noted according to each
location as plaque, peri-plaque (within 1 cm of the plaque)
and NAWM (far remote from the peri-plaque) (9). The images
are obtained with a b value of 1000 s/mm2. The independently
placed regions of interest (ROI) were assessed in the plaque
(in two different plaques), peri-plaque (in two differentregions) and NAWM (periventricular in frontal and occipital
regions).
At each pre-specified sites, two ADC values were obtained
by using (average areas of regions of interest ROI = 16.4
± 1.8 mm2). Mean values were used for statistical compar-
isons. In control groups, the mean ADC values from the four
Fig. 2 Bare chart representing mean ADC values of plaque,
periplaque and NAWM in the three groups.
Correlation of apparent diffusion coefficient to cognitive impairment 1013NAWM regions corresponding to the NAWM in MS patients
were calculated (Fig. 1).
2.5. Statistical analysis
The collected data were computerized and statistically ana-
lyzed using SPSS program (Statistical Package for Social
Science) version 18 (10). Qualitative data were represented as
frequencies and relative percentages. To calculate the differ-
ence between qualitative variables we used Chi-square test.
Quantitative data were expressed as mean ± SD (Standard
deviation). To calculate the difference between quantitative
variables in two groups in normally distributed data we used
independent T-test.
An analysis of variance ANOVA F-test test was used to cal-
culate the difference between quantitative variables in more
than two groups in normally distributed data.
Pearson correlation coefficient was used to calculate the
correlation between quantitative variables. We considered
(+) sign as an indicator of direct correlation and () sign asFig. 3 28 years-old Female patient with RRMS (4 years duration) a
multiple plaques, (b) DWI image showed signal intensity of facilitate
1.3428  103, Periplaque 0.8775  103, and NAWM 0.7928  103,an indicator of inverse correlation, and also, we considered
values near to 1 as strong correlation and values near 0 as
weak correlation.
The significance Level for all above-mentioned statistical
tests was done. The threshold of significance is fixed at 5%
level (p-value).
3. Results
Forty-five MS patients and 20 normal healthy control subjects
participated in this study. The mean age of the participant and
the gender distribution showed no significant differences
between groups (p= 0.63, p= 0.94 respectively). Demo-
graphic characteristics of the study groups are summarized
in Table 1.
3.1. Assessment of the cognitive functions
According to MOCA score all control subject had normal cog-
nition (above 26) with their mean MOCA score 27.70 ± 2.3.
Twenty-five cases (55.6%) out of the 45 MS patients had nor-
mal cognition with mean MOCA score 27.05 ± 2.3; however,
the other 20 (44.4%) patients had a cognitive impairment with
mean MOCA score 21.84 ± 2.2. In MS with cognitive impair-
ment group all the cognitive functions (visuospatial, executive,
attention, memory, fluency and orientation) were impaired
with a significant p-value (Table 2). According to ANOVA
test, there was a significant difference between MS patients
with cognitive impairment and the other two groups (control
and MS patients without cognitive impairment) as regards
MOCA scores (Table 2)
3.2. Mean ADC values of plaque, peri-plaque and NAWM
The mean ADC value of the plaque in the two MS groups
(impaired and normal cognition) was the highest
(1.198 ± 0.19  103 mm2/s and 1.225 ± 0.6  103 mm2/snd normal cognition (MOCA score 27). (a) Axial FLAIR showed
d diffusion, (c) ADC map showed the following readings: Plaque
0.7818  103 mm2/s.
Fig. 4 37 year-old male with RRMS, no relapse for 9 months and no cognitive impairment (MOCA score 28). (a) Axial FLAIR showed
multiple plaques, (b) DWI image showed signal intensity of facilitated diffusion, (c) ADC map showed the following readings:
Plaque1.1699  103, Periplaque 0.8656  103, and NAWM 0.791  103 mm2/s.
Fig. 5 38 year old female patient with RRMS and no relapse for 11 months with mild cognitive impairment (MOCA score 23). (a) Axial
FLAIR showed multiple plaques, (b) DWI image showed signal intensity of facilitated diffusion, (c) ADC map showed the following
readings: Plaque 1.4309  103, Periplaque 0.9231  103 and NAWM in image, (d) were 0.838  103 & 0.8013  103 mm2/s.
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plaques and each of the peri-plaque and NAWM (Fig. 2).
Also, the mean ADC values of peri-plaque in MS group
with cognitive impairment 0.939 ± 0.03  103 mm2/s (Figs. 5
and 7) were significantly higher (p< 0.001) than those of MS
group with normal cognition 0.837 ± 0.03  103 mm2/s
(Figs. 3 and 4 and 6). The mean ADC values of plaque, peri-
plaque and NAWM of the three groups were demonstrated
in Table 3.
The mean ADC values of NAWM in MS with impaired
cognition 0.819 ± 0.15  103 mm2/s were higher than MS
with normal cognition 0.7962 ± 0.03  103 mm2/s and
control groups 0.7154 ± 0.2  103 mm2/s (Table 3). It wasFig. 6 40-year-old female patient with RRMS and no cognitive im
plaques, (b) DWI image showed signal intensity of facilitated dif
1.1643  103, Periplaque 0.8491  103 and NAWM 0.8054  103 m
Fig. 7 39 year old male patient with RRMS and mild cognitive im
plaques, (b) DWI image showed signal intensity of facilitated dif
1.2644  103, Periplaque 0.9213  103, and NAWM 0.8488  103significantly higher in MS patient with cognitive impairment
(Figs. 5 and 7) than the control group (p< 0.05); however,
there was no significant difference between both MS groups
(p< 0.51), nor between normal cognitive MS patients and
control group (p< 0.08).
3.3. Correlation between ADC values and MOCA scores
The MS group with impaired cognition demonstrates a signif-
icant inverse correlation between the mean ADC values of the
peri-plaque region and MOCA scores (r= 0.64, p< 0.001).
The less significant inverse correlation was found between the
mean ADC values in the NAWM and MOCA scorespairment (MOCA score 26). (a) Axial FLAIR showed multiple
fusion, (c) ADC map showed the following readings: Plaque
m2/s.
pairment (MOCA score 19). (a) Axial FLAIR showed multiple
fusion, (c) ADC map showed the following readings: Plaque
mm2/s.
Table 4 Correlation results between ADC value in plaque,
periplaque and NAWM and cognition in the three groups.
Mean ADC MS group
with normal
cognition
MS group with
Cognitive
impairment
Control
group
r p r p r p
Plaque 0.15 0.07
NS
0.22 0.06 – –
Peri-plaque
white matter
0.12 0.12
NS
0.64 <0.001** – –
NAWM 0.16 0.06
NS
0.56 0.01* 0.09 0.27
NS
Fig. 8 Line graph shows correlation between ADC in peri-
plaque and NAWM and MOCA score in MS group with cognitive
impairment.
Table 3 The mean ADC values (ADC  103 mm2/s) in plaque, peri-plaque and NAWM in the 3 different groups.
MS group with normal cognition MS group with cognitive impairment Control group P
mean ± SD mean ± SD mean ± SD
Plaque 1.198 ± 0.19 1.225 ± 0.6 – 0.85
Peri-plaque white matter 0.837 ± 0.03 0.939 ± 0.03 – <0.001**
NAWM 0.796 ± 0.03 0.819 ± 0.15 0.715 ± 0.2 0.51A
0.08B
0.05*,C
F 53.16 53.78
P <0.001** <0.001**
LSD <0.001**,a <0.001**,a
<0.001**,b <0.001**,b
0.02*,c 0.10c
*p 6 0.05 (significant); **p 6 0.01 (highly significant).
A MS with normal cognition versus MS with impaired cognition.
B MS with normal cognition versus control.
C MS with impaired cognition versus control.
a Plaque versus Peri-plaque white matter.
b Plaque versus NAWM.
c Peri-plaque white matter versus NAWM.
1016 R.M. Almolla et al.(r= 0.56, p= 0.01). No significant correlation was found
between the mean ADC in plaque and MOCA scores
(r= 0.22, p= 0.06). Correlation results of the three groups
are demonstrated in Table 4 and Fig. 8.
4. Discussion
MR imaging is the first imaging modality for diagnosis and
follow-up of MS patients. The study of conventional MR
imaging alone is limited and has low specificity since areas of
edema, inflammation, gliosis, demyelination and axonal loss
display high signal on T2 WIs and FLAIR sequences. In addi-
tion, conventional MR imaging has a low ability to determine
the severity and extension of microscopic injuries on the
NAWM surrounding the plaques (11–14).
Demyelination is the primary pathological course in MS
(15). So quantitative information related to myelin destruction
may be calculated with DWI and the ADC maps, which reflect
the movement of water molecules in tissues (16,17).
In MS patients, ADC values of plaques and NAWM
detected on T2-WI and FLAIR were significantly higher than
the healthy control group (16–18). Guo et al. (12) found
abnormal ADC values in all assessed white matter regions inMS patients included in their study (12–19). This was similar
to our results as we found that, the mean ADC value of the
NAWM (0.819 ± 0.15  103 & 0.7962 ± 0.03  103 mm2/
s) in MS patients (with and without cognitive impairment
respectively) was higher than mean ADC of the control group
(0.7154 ± 0.2  103 mm2/s), with a significant difference
between the MS patients with cognitive impairment and the
control group (p< 0.05).
Guo et al. (19) also reported that the mean ADC of the pla-
que was (0.901 ± 0.095)  103 mm2/s with statistically signif-
icant differences between plaques and peri-plaque regions
(p< 0.001) and between plaques and NAWM (p< 0.001).
Also, in our study, we found that the mean ADC value of
the plaque in the two MS groups was the highest (1.198
± 0.19  103 mm2/s) and (1.225 ± 0.6  103 mm2/s) with
a significant difference (p< 0.001) between plaques and each
of the peri-plaque and NAWM.
ADC value in the peri-plaque region can be used as an indi-
cator of WM integrity and the risk of developing or deteriora-
tion of the cognitive state. In agreement with other hypotheses
Correlation of apparent diffusion coefficient to cognitive impairment 1017and histological supports of the extension of MS lesions
beyond the plaques (14,20–22) we found that the mean ADC
values in the peri-plaque regions in both MS groups (0.939
± 0.03 & 0.837 ± 0.03  103 mm2/s) were higher than mean
ADC of the NAWM (0.7154 ± 0.2  103 mm2/s) in control
group with significant difference (p< 0.001) only in the MS
patient with cognitive impairment.
However in studies by Ge et al. (23) and Caramia et al. (24)
they found no increase in the mean ADC in NAWM in MS
patient, and the difference between these studies and ours
may be attributed to the small number of the patients included
in the first study (only 15) (23) or exposure of the patients to a
single attack in the second study (24).
Neurocognitive dysfunction in MS patients has been
reported to occur in approximately 40–70% (25–27). This
was coping with our study as the cognitive impairment was
detected in 44.4% of our MS patients according to MOCA
scale and showed a significant difference between MS without
cognitive impairment and control groups.
In MS patients, cognitive impairment has been reported in
all stages of the disease, so early diagnosis of cognitive impair-
ment is important, as it can predict the rate of disease progres-
sion, and help the patients to accept different disease-
modifying treatments (28–30).
Other studies had proved a significant correlation between
the cognitive performance and NABT in many diseases (31).
Baseline findings from multinational Leukoaraiosis and Dis-
ability study (LADIS) (32) had reported that in NABT,
DWI metrics are significantly associated with cognitive perfor-
mance, but not within white matter hyperintensities
In agreement with many similar studies (26,33–35), we
found that all the cognitive functions (visuospatial, executive,
attention, memory, fluency and orientation) were impaired
with a significant p-value (p value < 0.05) only in MS patients
with cognitive impairment.
A moderate correlation among normal-appearing brain tis-
sue, both white and gray matter and cognitive testing was
found by DT-MRI techniques (4). In accordant with our
study, in MS patient with cognitive impairment, there was
an inverse (ve) correlation with the mean ADC value in the
peri-plaque and cognitive state according to MOCA scores
(r= 0.64, p< 0.001). The less significant inverse correlation
was found between the mean ADC values of NAWM and
MOCA scores (r= 0.56, p< 0.01). No significant correla-
tion was found between the ADC of plaque and MOCA scores
(r= 0.22, p< 0.06).
Because of limited acquisitions in our institute, we used
only the mean ADC from DW-MRI as an indicator of cell
destruction and water diffusivity and ignored measuring the
neural integrity via fractional anisotropy. We did not study
the association between each individual cognitive function
and mean ADC value, and also, there was no statistical anal-
ysis of the most affected cognitive function.
5. Conclusions
Hidden microstructural pathological changes in NAWM of
MS patients can be detected by new imaging techniques such
as DW-MRI. ADC values can be used as an useful biomarker
to monitor the extent of brain damage Correlations between
cognitive dysfunction and neuroimaging parameters, such asmean ADC, can predict MS patients susceptible to cognitive
dysfunction and so modify the disease course.Conﬂict of interest
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